Research and advisory services company Corporate Executive Board Co. (EXBD) or CEB Monday said it has entered into an alliance with equities exchange group NYSE Euronext, Inc. (NYX) that will offer NYSE-listed companies exclusive benefits drawn from CEB's proprietary data and insights.
CEB also said it would also enable the NYSE to deliver deeper, more actionable business insights around corporate performance and investor perspectives to its listed companies.
The CEB/NYSE relationship will focus initially on offerings from CEB's Finance and Strategy Practice. NYSE-listed CFOs and heads of IR who are interested in CEB membership will be offered exclusive benefits, including the NYSE Market Valuation Diagnostic.
According to CEB, the NYSE Market Valuation Diagnostic is a sophisticated analytical tool developed to meet the distinct needs of NYSE-listed companies. The tool combines a listed company's historical performance, current valuation, and analyst estimates to provide a view of key valuation drivers and strategies for closing valuation gaps drawn from CEB's deep analysis of corporate best practices.
"This alliance will help NYSE-listed companies drive corporate performance by arming them with actionable data and analysis," said Thomas Monahan, III, CEB Chairman and CEO.
Beyond the exclusive membership offerings, NYSE will broaden its popular Digital Exchange webinar series to include CEB's proprietary content. In addition, NYSE's global CFO and investor relations roundtables and networking events will include CEB leadership, who will address emerging trends and issues.
CEB also announced today that it will transfer the listing of its common stock to the NYSE. CEB expects to begin trading on the NYSE on Aug. 20, 2010, using its current symbol "EXBD." The company will continue to trade on the NASDAQ until the transfer is completed.
For comments and feedback: editorial@rttnews.com